NovAliX seminars in Japan

Feb 06, 2024

NovAliX seminars in Japan, February 2024

NovAliX’s team at our Tokyo subsidiary organized a series of seminars tailored to the Japanese pharmaceutical industry on February 6 and 7, 2024. We were delighted to welcome many participants to two exclusive sessions held at the French Embassy in Tokyo and Osaka.

Insightful presentations were delivered by Dr. Denis Zeyer, CEO, Marco Pintore, SVP – Business Development & Marketing, and Daisuke Tanaka, Senior Director of Business Development in Japan. Their discussions on the advanced use of biophysics and cryo-electron microscopy for characterizing membrane proteins, alongside innovative strategies for PROTAC development using DEL technology, fostered significant interaction and knowledge exchange among participants.

This event highlighted the strong demand for customized solutions for complex projects, an area where our capabilities in Japan are perfectly aligned with market needs.

Our NovAliX seminars in Japan in February 2024

Visit our dedicated pages if you want to get more details on biophysics, cryo-EM and our DEL platform.

Contact us!

Date

From Feb 06, 2024
to Feb 07, 2024

Location

Tokyo, Japan

Attendees

Denis Zeyer
CEO

Marco Pintore
SVP - Business Development & Marketing

Daisuke Tanaka
Senior Director of Business Development in Japan

Alain Decayeux
Managing Director Asia-Pacific

Looking for more information on drug discovery?